Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127009571 | 12700957 | 1 | I | 20160815 | 20160831 | 20160831 | EXP | TH-MLMSERVICE-20160809-0386844-1 | TH-ALKEM LABORATORIES LIMITED-TH-ALKEM-2016-00138 | ALKEM | 62.00 | YR | F | Y | 0.00000 | 20160830 | CN | GB | TH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127009571 | 12700957 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNKNOWN | Y | 91249 | ||||||||||
| 127009571 | 12700957 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNKNOWN | 0 | |||||||||||
| 127009571 | 12700957 | 3 | SS | TACROLIMUS. | TACROLIMUS | 1 | UNKNOWN | Y | 0 | ||||||||||
| 127009571 | 12700957 | 4 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 2000 MG, UNK | 0 | 2000 | MG | ||||||||
| 127009571 | 12700957 | 5 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 | ||||||||||||
| 127009571 | 12700957 | 6 | C | BASILIXIMAB | BASILIXIMAB | 1 | UNKNOWN | 0 | |||||||||||
| 127009571 | 12700957 | 7 | C | GANCICLOVIR. | GANCICLOVIR | 1 | UNKNOWN | 0 | |||||||||||
| 127009571 | 12700957 | 8 | C | GANCICLOVIR. | GANCICLOVIR | 1 | 0 | ||||||||||||
| 127009571 | 12700957 | 9 | C | IMMUNGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 115 G, UNK | 0 | 115 | G | ||||||||
| 127009571 | 12700957 | 10 | C | IMMUNGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127009571 | 12700957 | 1 | Immunosuppression |
| 127009571 | 12700957 | 2 | Immunosuppression |
| 127009571 | 12700957 | 3 | Immunosuppression |
| 127009571 | 12700957 | 4 | Transplant rejection |
| 127009571 | 12700957 | 5 | Transplant rejection |
| 127009571 | 12700957 | 6 | Product used for unknown indication |
| 127009571 | 12700957 | 7 | Cytomegalovirus infection |
| 127009571 | 12700957 | 8 | Pancytopenia |
| 127009571 | 12700957 | 9 | Transplant rejection |
| 127009571 | 12700957 | 10 | Transplant rejection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127009571 | 12700957 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127009571 | 12700957 | Polyomavirus-associated nephropathy | |
| 127009571 | 12700957 | Ureteric obstruction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |